Fate Therapeutics
FATE
FATE
156 hedge funds and large institutions have $1.76B invested in Fate Therapeutics in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 56 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 147 → 156 (+9)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 56
Holders
156
Holding in Top 10
6
Calls
$11.7M
Puts
$4.79M
Top Buyers
| 1 | +$73M | |
| 2 | +$60.4M | |
| 3 | +$42M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$32.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$31.6M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$17.2M | |
| 3 | -$15.3M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$14.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$13.6M |